Iterum Therapeutics Announces Collaboration with EVERSANA to Support Oral Sulopenem Launch
DUBLIN, Ireland and CHICAGO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical...
Day: February 1, 2021
EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation
- Franz Obermayr, Ph.D. Appointed as Acting Chief Executive Officer, Transitioning From EVP Clinical Development - - Stephen From Elevated...
Quotient Limited Reports Third Quarter Fiscal 2021 Results and Business Update
MosaiQ COVID-19 semi-quantitative antibody test CE markedExpanded MosaiQ IH microarray EU launch planned for fourth quarter CY2021Sales of Alba by...
Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®
– LYPDISO™ demonstrated a statistically significant 46% relative percent increase in EPA change from baseline over Vascepa® – – LYPDISO™...
Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada
- Coherus to pay $150 million upfront for U.S. and Canada rights to toripalimab, an extensively studied, late-stage anti-PD-1 antibody-...
Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution Now Available in Germany for the Treatment of Seizures in Dravet Syndrome
FINTEPLA offers a new treatment option for patients in Germany with Dravet syndrome, a rare, devastating, infant-onset epilepsy marked by...
Zealand Pharma completes registration of capital increase
Company announcement – No. 4 / 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR...
Registration of share capital increase of 4,711,832 new B shares completed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH...
Valneva Announces UK Government Exercise of Option for 40 Million Doses of its Inactivated, Adjuvanted COVID-19 Vaccine
Saint-Herblain (France), February 1st, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on prevention against...
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular...
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS--Novo Integrated Sciences, Inc. (OTCQB:NVOS) (OTCQB:NVOSD), a provider of multi-dimensional primary healthcare services and products in Canada and...
HARRIS Flex Upgrades to InterSystems IRIS for Health™
Technology migration expands interoperability and enhances patient care across 60 hospital systems throughout North America, Europe, and Middle East. CAMBRIDGE,...
ConnectiveRx Announces Exclusive Partnership with Veradigm to Deliver High-Impact Point-of-Care Communications
Formation of new premium EHR network reaches more than 130 million patients, helps prescribers improve health outcomes WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx,...
Senseonics Announces Initiation of European Commercial Efforts by Partner Ascensia Diabetes Care
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term,...
LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. O’Farrell
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq:LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions...
Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC...
Grapefruit USA, Inc. Announces Its Disruptive Hourglass(TM) Time Release THC+CBD Delivery Cream Is Now Available on Weedmaps Retail Website
LOS ANGELES and DESERT HOT SPRINGS, CA / ACCESSWIRE / February 1, 2021 / Grapefruit USA, Inc., (OTCQB:GPFT) ("Grapefruit" or...
AiCuris Changes its Legal Form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
Transition will support the Company in exploring additional opportunities for future growth AiCuris shareholders elect Helga Rübsamen-Schaeff, Sean Marett and...
Evotec CSO Cord Dohrmann Appointed to German Council of Science and Humanities
HAMBURG, GERMANY / ACCESSWIRE / February 1, 2021 / Evotec (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that...